Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders
Learn more about:
Related Clinical Trial
Validation of 5-Point Investigator Global Assessments for Pemphigus
The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders
Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
Wound Dressings for Pemphigus and Pemphigoid
Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus
Effect of Anti CD20 in Pemphigus Desease
Identification of Vulnerability Factors in the Course of Pemphigus Patients
Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex